Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot Study

Sponsor
Medical University of Vienna (Other)
Overall Status
Completed
CT.gov ID
NCT01843101
Collaborator
(none)
13
1
3
31.4
0.4

Study Details

Study Description

Brief Summary

The aim of the present study is to develop a protocol for optimal corneal 3-dimensional imaging based on measurements in healthy volunteers. For this purpose, a customized ultra-high resolution Spectral Domain OCT will be used. To validate whether the protocol can also be applied in patients with corneal pathologies, for whom it is intended to be used, measurements in these patients will be performed. We propose to obtain images from patients with keratoconus, since this is one of the most frequent causes for corneal transplantations in Europe and from patients with corneal neovascularization which is a major cause of vision loss in several ophthalmic diseases. Based on the obtained measurement protocol, further studies investigating the pathophysiology or treatment success of several corneal pathologies can be planned.

Condition or Disease Intervention/Treatment Phase
  • Device: Optical Coherence Tomography
Phase 2

Study Design

Study Type:
Interventional
Actual Enrollment :
13 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot Study
Actual Study Start Date :
Mar 14, 2014
Actual Primary Completion Date :
Oct 24, 2016
Actual Study Completion Date :
Oct 24, 2016

Arms and Interventions

Arm Intervention/Treatment
Other: Healthy volunteers

10 healthy volunteers

Device: Optical Coherence Tomography
Imaging of the cornea using ultrahigh resolution Spectral Domain OCT

Other: Corneal Neovascularisation

5 patients with corneal neovascularisation

Device: Optical Coherence Tomography
Imaging of the cornea using ultrahigh resolution Spectral Domain OCT

Other: Keratoconus

5 patients with keratoconus

Device: Optical Coherence Tomography
Imaging of the cornea using ultrahigh resolution Spectral Domain OCT

Outcome Measures

Primary Outcome Measures

  1. Corneal Imaging [1 day]

    Development of a measurement protocol for 3 dimensional imaging of the human cornea

Secondary Outcome Measures

  1. Imaging of corneal pathologies [1 day]

    Application of the protocol in patients with corneal pathologies

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
Healthy volunteers:
  • Men and women aged over 18 years

  • Normal findings in the slit lamp examination, no corneal pathologies

Patients with keratoconus:
  • Men and women aged over 18 years

  • Presence of keratoconus

  • No ophthalmic surgery in the 3 months preceding the study

Patients with corneal neovascularization:
  • Men and women aged over 18 years

  • Presence of corneal neovascularization

  • No ophthalmic surgery in the 3 months preceding the study

Exclusion Criteria:
  • Participation in a clinical trial in the previous 3 weeks

  • Presence of any abnormalities preventing reliable measurements as judged by the investigator

  • Pregnancy, planned pregnancy or lactating

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Clinical Pharmacology Vienna Austria 1090

Sponsors and Collaborators

  • Medical University of Vienna

Investigators

  • Principal Investigator: Katarzyna Napora, MD, PhD, Department of Clinical Pharmacology, Medical University of Vienna

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Gerhard Garhofer, Assoc. Prof. PD Dr., Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT01843101
Other Study ID Numbers:
  • OPHT-040413
First Posted:
Apr 30, 2013
Last Update Posted:
Sep 8, 2021
Last Verified:
Aug 1, 2021
Keywords provided by Gerhard Garhofer, Assoc. Prof. PD Dr., Medical University of Vienna
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 8, 2021